Back to Blog

Common Errors in Medical Translation: A Regulatory Risk Perspective

Medical translation errors can lead to FDA warning letters, product recalls, clinical trial delays.

Common Errors in Medical Translation: A Regulatory Risk Perspective

Abstract: Medical translation errors can lead to FDA warning letters, product recalls, clinical trial delays, and patient safety risks.

1. Regulatory Submission Errors

Common Mistakes

  • Inconsistent terminology: Same term translated differently in 510(k) and PMA submissions
  • Critical parameter mistranslation: Deviations in product specifications, indications, contraindications
Real Case
In 2023, a medical device company received an FDA Warning Letter due to mistranslation of product indications, resulting in a 6-month market ban in the US and direct losses exceeding $2 million.

Consequences

  • ⚠️ FDA Warning Letter
  • ⚠️ Approval delays
  • ⚠️ Product recall
  • ⚠️ Market exclusion

2. Clinical Trial Document Issues

High-Risk Documents

  1. Informed Consent Form (ICF)
  2. Investigator's Brochure (IB)
  3. Case Report Form (CRF)

Consequences

  • ⚠️ Ethics committee rejection
  • ⚠️ Invalid clinical trial data
  • ⚠️ Patient safety risks

3. Label and IFU Errors

Consequences

  • ⚠️ Product recall
  • ⚠️ Customs detention
  • ⚠️ Legal litigation

4. Pharmacovigilance Document Issues

Consequences

  • ⚠️ Regulatory penalties
  • ⚠️ Drug withdrawal risk

5. AI Translation Boundaries

Best Practices
✅ Professional medical translator review
✅ Validated terminology databases (MedDRA, ICD)
✅ Translation memory for consistency
✅ Dual-review system

6. Choosing a Compliant Vendor

Evaluation Criteria

DimensionRequirements
Translator QualificationsMedical/Pharmaceutical background + Translation certification
Quality SystemISO 17100, ISO 13485 certification
Terminology ManagementStandardized terminology (MedDRA, ICD-10)
Review ProcessTranslation + Editing + Proofreading (TEP)
Warning Signs ⚠️
❌ No medical case studies
❌ Translators without medical background
❌ Prices too low
❌ No review process

💡 Key Takeaways

  1. Choose professional teams
  2. Use standard terminology
  3. Strict review process
  4. Continuous terminology management
  5. Compliance awareness

📞 Get Professional Medical Translation Services

SmartLang's Medical Translation Team consists of senior translators with medical and pharmaceutical backgrounds.

✅ FDA/CE/NMPA submission translation
✅ Clinical trial document translation
✅ Medical device label translation
✅ Pharmacovigilance document translation

👉 Get a Quote Today: https://smartlangservice.com/contact/

Free initial consultation, response within 24 hours.